ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden

Blood Cancer Journal, Published online: 12 October 2020; doi:10.1038/s41408-020-00364-5ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden

Source: Blood Cancer Journal - October 12, 2020 Category: Hematology Authors: Yu-Hung Wang Chien-Chin Lin Sze-Hwei Lee Cheng-Hong Tsai Shan-Ju Wu Hsin-An Hou Tai-Chung Huang Yuan-Yeh Kuo Ming Yao Koping Chang Chung-Wu Lin Yun-Chu Lin Fen-Ming Tien Wen-Chien Chou Jih-Luh Tang Hwei-Fang Tien Source Type: research